Institutional investors purchased a net $10.5 million shares of SGEN during the quarter ended December 2017 and now own 106.04% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 4.3 Million shares of Seattle Genetics Inc
BAKER BROS. ADVISORS LP Bought 3.9 Million shares of Seattle Genetics Inc
MANNING & NAPIER ADVISORS LLC Bought 2.5 Million shares of Seattle Genetics Inc